SMR
ECR SUB-COMMITTEE
Our mission is to cultivate an inclusive and supportive environment for early career researchers (ECRs) in the field of medicines research. In collaboration with the main SMR committee, we aim to enhance engagement, participation, and opportunities for ECRs at SMR events. We endeavour to provide resources, mentorship, and networking platforms that will aid the ECR community to contribute meaningfully to the advancement of medicines research.
ECR Chair:
Ms Chloe Oxford
Chloe is a Scientist based at GSK in Stevenage, where she supports early drug discovery projects in the Biology R&D organisation. Chloe joined GSK as a Degree Apprentice in September 2020 and completed her BSc in Applied Bioscience in July 2025 with the University of Kent. Chloe is an active STEM ambassador and member of the GSK Stevenage STEM committee with a passion for inspiring the next generation into scientific careers through organising careers fairs and work experience events. Chloe has joined the SMR Early Career Researcher (ECR) subcommittee as she is enthusiastic about the development of early career professionals and students in the scientific research community. She is excited about working with the subcommittee to increase engagement of ECR’s at SMR events and collaborating with other scientists across industry and academia.
Mr Aitor Carneiro Viqueira
Aitor is a PhD student at The University of Manchester, focused on the development of new synthetic methodologies and their application to chemical biology and drug discovery. Originally from Spain, he completed his undergraduate studies at the University of Santiago de Compostela in 2020, followed by a MSc in Medicinal Chemistry at Cardiff University in 2021.
Dr Efthymios Spyridon Gavriil
Dr. Efthymios Gavriil obtained his PhD in Medicinal Chemistry in 2018 from the University of Athens. In his PhD, he worked on novel substituted purine isosteres as anti-cancer agents, focusing on kinase inhibitors. Then, during his three-year postdoc at the Drug Discovery Unit of Cancer Research UK Manchester Institute, he contributed to the progression of two kinase inhibition projects at the hit-to-lead and lead optimisation stages. In 2022, he joined Prof. Ed Tate’s group at Imperial, as a Research Associate in Medicinal Chemistry and Cancer Drug Discovery. He is currently leading several drug discovery projects in the areas of oncology, immunology and neglected tropical diseases. Efthymios is also a member of ‘PostdoCaRe Europe: The European Network for Postdocs in Cancer Research'
Dr Pol Hernandez Llado
Pol is a Novo Nordisk Postdoctoral Research Fellow at the University of Oxford, where his work sits at the interface of medicinal chemistry and chemical biology. His research focuses on identifying new therapeutic targets for metabolic diseases. He holds a degree in Chemistry from the University of Barcelona and a DPhil from the University of Oxford. Pol joined the SMR ECR subcommittee after attending several excellent SMR events and is particularly keen to develop initiatives that engage early-career researchers and highlight the value of industry–academia collaboration.
Dr William McCarthy
William is a Postdoctoral Fellow at the Francis Crick Institute, working in close collaboration with the Chemical Biology Department at GSK. He completed his PhD under the supervision of Prof. Chris Abell in the Chemistry Department at the University of Cambridge. During his doctoral research, he developed and applied fragment-based drug discovery methods to identify inhibitors targeting Coenzyme A biosynthesis in Mycobacteria. His current research leverages proteomics techniques to profile covalent fragment libraries against the human proteome. He is particularly focused on exploring chemical design principles to refine fragment libraries and expand the ligandable proteome.
Dr Darren Richards
Darren is a Postdoctoral Research Associate at the University of Bath, working under the supervision of Dr Scott Lovell. He completed his PhD at the same institution, where he conducted research in synthetic organic chemistry under the supervision of Dr Alex Cresswell. During this time, his doctoral work was focused on developing new methodologies to access medicinally valuable amine-containing building blocks using photoredox catalysis. Following his PhD, Darren transitioned into the field of chemical biology. His current research is centred on the development of covalent inhibitors designed to target challenging protein binding sites, with the aim of advancing new treatments for cancer therapeutics.
Ms Gwenno Rowlands
Gwenno is a PhD student in Medicinal Chemistry at Cardiff University based in the Medicines Discovery Institute. Her research focuses on developing small-molecule inhibitors targeting an enzyme implicated in multiple diseases. Gweeno’s project is funded by The Coleg Cymraeg Cenedlaethol, enabling her to conduct her research through the medium of Welsh.
Dr Jess Stacey
Jess Stacey completed an MChem with an Industrial Placement from Newcastle University in 2017, where she first was introduced to chemoinformatics at her placement with MedChemica. Jess then went to Sheffield to undertake a PhD in chemoinformatics under the supervision of Professor Val Gillet and Stephen Pickett (GSK), which entitled “Data Mining for Lead Optimisation”. In November 2022 she returned to MedChemica. Since then, she has created a matched molecular pair scaffold hopping tool, CoreDesign®. For the past year Jess has been part of the ASAP consortium where she has been designing new compounds within the lead optimisation stage, which has led her to her most recent work on time series analysis of the SAR around the most promising scaffold.